We found that these interface genes were involved in well-known cancer signaling networks (e.g. TP53, NF1, PIK3CA), but found that other processes of emerging interest, such as metabolism and mithochondrial dysregulation are also associated with the rupturing of regulation of unicellular and multicellular components by point mutations. The gene discussed is TP53; the disease is cancer.